Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T. Rowe Price Equity Income ETF | TEQI | Nov 22, 2024 | 43.23 | +0.74 |
T. Rowe Price Group | TROW | Nov 22, 2024 | 119.84 | +1.40 |
T. Rowe Price Growth Stock ETF | TGRW | Nov 22, 2024 | 39.46 | 0.00 |
T2 Biosystems | TTOO | Nov 22, 2024 | 0.51 | +19.77 |
Taboola.com | TBLA | Nov 22, 2024 | 3.53 | -2.22 |
Tactile Systems Technology | TCMD | Nov 22, 2024 | 17.85 | +11.98 |
Taitron Components A | TAIT | Nov 22, 2024 | 2.56 | -2.84 |
Taiwan Fund | TWN | Nov 22, 2024 | 43.18 | +2.08 |
Taiwan Index MSCI Ishares | EWT | Nov 22, 2024 | 54.24 | +0.93 |
Taiwan Semiconductor Manufacturing ADR | TSM | Nov 22, 2024 | 190.08 | -0.61 |
Take-Two Interactive Software | TTWO | Nov 22, 2024 | 188.15 | +0.84 |
Takeda Pharmaceutical ADR | TAK | Nov 22, 2024 | 13.38 | +0.38 |
TAL Education Group ADR | TAL | Nov 22, 2024 | 9.73 | -0.82 |
Talen Energy | TLN | Nov 22, 2024 | 214.20 | -2.59 |
Talkspace | TALK | Nov 22, 2024 | 3.45 | +4.23 |
Talos Energy | TALO | Nov 22, 2024 | 11.45 | -1.04 |
Talphera | TLPH | Nov 22, 2024 | 0.70 | -0.59 |
Tamboran Resources | TBN | Nov 22, 2024 | 17.25 | -7.16 |
Tandem Diabetes Care | TNDM | Nov 22, 2024 | 30.81 | +0.23 |
Tanger | SKT | Nov 22, 2024 | 36.49 | -0.49 |
Tango Therapeutics | TNGX | Nov 22, 2024 | 3.92 | +7.99 |
Tantech | TANH | Nov 22, 2024 | 0.15 | +1.42 |
Taoping | TAOP | Nov 22, 2024 | 0.34 | -4.37 |
Tapestry | TPR | Nov 22, 2024 | 58.92 | +4.45 |
Targa Resources | TRGP | Nov 22, 2024 | 207.31 | -0.18 |
Target | TGT | Nov 22, 2024 | 125.01 | +2.81 |
Target Global Acquisition I A | TGAA | Nov 22, 2024 | 11.35 | +0.27 |
Target Global Acquisition I Unit | TGAAU | Nov 22, 2024 | 11.28 | 0.00 |
Target Hospitality | TH | Nov 22, 2024 | 8.71 | -0.68 |
Tarsus Pharmaceuticals | TARS | Nov 22, 2024 | 48.24 | +3.97 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.